MARKET

ABMD

ABMD

Abiomed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

265.07
-11.07
-4.01%
After Hours: 265.07 0 0.00% 16:58 09/18 EDT
OPEN
275.23
PREV CLOSE
276.14
HIGH
275.94
LOW
260.95
VOLUME
539.12K
TURNOVER
--
52 WEEK HIGH
319.19
52 WEEK LOW
119.01
MARKET CAP
11.94B
P/E (TTM)
76.19
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average ABMD stock price target is 326.40 with a high estimate of 365.00 and a low estimate of 217.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ABMD
ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of ABIOMED, Inc. stock information, including NASDAQ:ABMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABMD stock methods without spending real money on the virtual paper trading platform.